My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway.

    Kase ET, Wensaas AJ, Aas V, Højlund K, Levin K, Thoresen GH, Beck-Nielsen H, Rustan AC, Gaster M.

    Diabetes. 2005 Apr;54(4):1108-15.PMID: 15793250 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.

    Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti JR Jr, Henry RR.

    Diabetologia. 2001 Apr;44(4):444-52.PMID: 11357475 [PubMed - indexed for MEDLINE]Related articles

    3.

    Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.

    Kase ET, Thoresen GH, Westerlund S, Højlund K, Rustan AC, Gaster M.

    Diabetologia. 2007 Oct;50(10):2171-80. Epub 2007 Jul 28.PMID: 17661008 [PubMed - indexed for MEDLINE]Related articles

    4.

    Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

    Green CD, Jump DB, Olson LK.

    Endocrinology. 2009 Jun;150(6):2637-45. Epub 2009 Feb 19.PMID: 19228891 [PubMed - indexed for MEDLINE]Related articles

    5.

    Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.

    Beyer TP, Schmidt RJ, Foxworthy P, Zhang Y, Dai J, Bensch WR, Kauffman RF, Gao H, Ryan TP, Jiang XC, Karathanasis SK, Eacho PI, Cao G.

    J Pharmacol Exp Ther. 2004 Jun;309(3):861-8. Epub 2004 Feb 11.PMID: 14960661 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.

    Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE.

    Mol Endocrinol. 2003 Dec;17(12):2477-93. Epub 2003 Oct 2.PMID: 14525954 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.

    Cozzone D, Debard C, Dif N, Ricard N, Disse E, Vouillarmet J, Rabasa-Lhoret R, Laville M, Pruneau D, Rieusset J, Lefai E, Vidal H.

    Diabetologia. 2006 May;49(5):990-9. Epub 2006 Feb 16.PMID: 16482468 [PubMed - indexed for MEDLINE]Related articles

    8.

    On the role of liver X receptors in lipid accumulation in adipocytes.

    Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KA, Hollung K, Haugen F, Jacinto S, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI.

    Mol Endocrinol. 2003 Feb;17(2):172-82.PMID: 12554745 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Exercise training increases lipid metabolism gene expression in human skeletal muscle.

    Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M, Cameron-Smith D.

    Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E66-72.PMID: 12067844 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.

    Al-Khalili L, Bouzakri K, Glund S, Lönnqvist F, Koistinen HA, Krook A.

    Mol Endocrinol. 2006 Dec;20(12):3364-75. Epub 2006 Aug 31.PMID: 16945991 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.

    Wójcicka G, Jamroz-Wiśniewska A, Horoszewicz K, Bełtowski J.

    Postepy Hig Med Dosw (Online). 2007 Dec 3;61:736-59. Review.PMID: 18063918 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.

    Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, Tontonoz P.

    Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5419-24. Epub 2003 Apr 15.PMID: 12697904 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.

    Thomas J, Bramlett KS, Montrose C, Foxworthy P, Eacho PI, McCann D, Cao G, Kiefer A, McCowan J, Yu KL, Grese T, Chin WW, Burris TP, Michael LF.

    J Biol Chem. 2003 Jan 24;278(4):2403-10. Epub 2002 Nov 18.PMID: 12441342 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.

    Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF.

    J Biol Chem. 2005 Nov 18;280(46):38317-27. Epub 2005 Sep 22.PMID: 16179348 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway.

    Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE.

    J Biol Chem. 2005 Apr 1;280(13):12573-84. Epub 2005 Jan 6.PMID: 15640143 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.

    Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A.

    J Biol Chem. 2007 Jul 6;282(27):19313-20. Epub 2007 May 11.PMID: 17500064 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.

    Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC.

    J Lipid Res. 2006 Feb;47(2):366-74. Epub 2005 Nov 21.PMID: 16301737 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.

    Jucker BM, Yang D, Casey WM, Olzinski AR, Williams C, Lenhard SC, Legos JJ, Hawk CT, Sarkar SK, Newsholme SJ.

    Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1256-64. Epub 2007 Aug 28.PMID: 17726146 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.

    Pimenta AS, Gaidhu MP, Habib S, So M, Fediuc S, Mirpourian M, Musheev M, Curi R, Ceddia RB.

    J Cell Physiol. 2008 Nov;217(2):478-85.PMID: 18561258 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity